Vincerx Pharma, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 12.43 million compared to USD 14.65 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 0.69 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 USD | +9.46% |
|
+35.00% | -31.36% |
05-14 | Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-26 | Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.36% | 23.92M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- VINC Stock
- News Vincerx Pharma, Inc.
- Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024